Skip to the content
REVOLUTIONIZING TREATMENT DECISIONS
Follow us on
Home
Solutions
INNOVATIVE TRIAL DESIGN
Inform Strategic Decisions
Benefit-Risk Assessment
Resources
Net Treatment Benefit
Regulatory submissions
Blogs
Case studies
Peer-reviewed papers
About
About One2Treat
One2Treat’s Team
Contact
Careers
Get in touch
Home
Solutions
INNOVATIVE TRIAL DESIGN
Inform Strategic Decisions
Benefit-Risk Assessment
Resources
Net Treatment Benefit
Regulatory submissions
Blogs
Case studies
Peer-reviewed papers
About
About One2Treat
One2Treat’s Team
Contact
Careers
Blogs
▶
Webinar
Rare Disease
Sjogren Disease
Beyond Traditional Endpoints: a patient-focused approach to enhancing rare disease trials
Back
Read also
Blogs
Reactions to Being “Powered By Purpose” on Clinical Trials Day 2025
READ MORE
→
Blogs
Why patient-centric trial design is the future of oncology: Q&A with One2Treat’s chief medical officer Pascal Piedbois
READ MORE
→
Blogs
Enhancing Patient-Centric Clinical Trials with the Net Treatment Benefit Methodology
READ MORE
→
Press Release
Press Release: One2Treat launches One2Treat Voice app
READ MORE
→
Want to invest in a more holistic understanding
of net treatment benefit?
Get in touch